Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with room-temperature stability under ...

The nonprofit operating the controversial facilities doesn't track outcomes for patients experiencing cardiac arrest, strokes ...

Comedian Park Na-rae, 40 years old, has faced allegations of receiving illegal medical treatments, following prior ...

Comedian Park Na-rae, who has faced allegations of power abuse against her manager and embezzlement suspicions, is now under scrutiny for allegedly receiving unauthorized medical treatment. The ...

Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is one of many planned injectable drugs B. Braun will launch in the U.S. in the next several years to expand its portfolio and help meet ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 ...

Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...

LOWELL — The City Council voted Tuesday evening to prohibit safe injection sites within the city ahead of proposed bills in the Legislature that would allow such facilities in Massachusetts.

Outside the South Riverdale Community Health Centre in Leslieville, Toronto. The province of Ontario did something last month it has never done before — it defunded a supervised injection site because ...

Cosentyx (secukinumab) comes as a subcutaneous injection under the skin or an intravenous (IV) infusion into a vein. Doctors may prescribe it to treat plaque psoriasis, psoriatic arthritis, and other ...